FDA Approves Mounjaro for Weight Loss Use, to Be Sold Under New Zepbound Name
Approval comes amid growing reports of stomach paralysis from Mounjaro, Ozempic and similar drugs, which have led to a number of lawsuits over failure to warn about the potential side effects